Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.08 USD | -0.99% | -6.89% | -22.75% |
Financials (USD)
Sales 2024 * | 598M | Sales 2025 * | 768M | Capitalization | 5.7B |
---|---|---|---|---|---|
Net income 2024 * | -575M | Net income 2025 * | -544M | EV / Sales 2024 * | 8.59 x |
Net cash position 2024 * | 567M | Net Debt 2025 * | 318M | EV / Sales 2025 * | 7.84 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-11.2
x | Employees | 927 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.13% |
Latest transcript on Ionis Pharmaceuticals, Inc.
1 day | -0.99% | ||
1 week | -6.89% | ||
Current month | -5.28% | ||
1 month | -8.05% | ||
3 months | -23.97% | ||
6 months | -15.70% | ||
Current year | -22.75% |
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 12-06-30 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 00-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 14-02-02 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Joan Herman
BRD | Director/Board Member | 70 | 19-06-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.89% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 39.08 | -0.99% | 895,065 |
24-05-09 | 39.47 | -1.72% | 1,300,598 |
24-05-08 | 40.16 | -1.88% | 1,527,136 |
24-05-07 | 40.93 | -3.19% | 1,211,831 |
24-05-06 | 42.28 | +0.74% | 928,265 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.75% | 5.7B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- IONS Stock